Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990523218> ?p ?o ?g. }
- W1990523218 endingPage "1016" @default.
- W1990523218 startingPage "1007" @default.
- W1990523218 abstract "BACKGROUND Targeting of plasminogen activators to the thrombus by means of fibrin-specific monoclonal antibodies may enhance their thrombolytic potency. The kinetics of clot binding of two human fibrin-specific monoclonal antibodies (MA-12B3 and MA-15C5) and of clot lysis with their chemical 1:1 stoichiometric complexes with recombinant single-chain urokinase-type plasminogen activator (rscu-PA) (rscu-PA/MA-12B3 and rscu-PA/MA-15C5) were determined in hamsters and rabbits. Thrombolytic potencies, maximal rates of clot lysis, and the duration of the lag phases before clot lysis of the antibody/rscu-PA conjugates were compared with those of rscu-PA and tissue-type plasminogen activator (rt-PA). METHODS AND RESULTS Bolus injection of 7.5 micrograms of 125I-labeled antibody in rabbits with an extracorporeal arteriovenous loop containing a 0.3-mL human plasma clot produced clot-to-blood ratios of 6.6 +/- 1.0 (mean +/- SEM) for MA-12B3 and 1.1 +/- 0.15 for MA-15C5 (p < 0.001 versus MA-12B3) within 6 hours. Progressive digestion of the clot did not alter the binding of MA-12B3 but resulted in as much as a 10-fold increase of the binding of MA-15C5. The conjugates infused intravenously over 90 minutes in hamsters with a human plasma clot in the pulmonary artery produced dose-related in vivo clot lysis. Thrombolytic potencies (maximal slope of the percent lysis versus dose in milligrams of u-PA equivalent per kilogram body weight) were 2,500 +/- 440 for rscu-PA/MA-12B3, 3,600 +/- 640 for rscu-PA/MA-15C5 (p = NS vs. rscu-PA/MA-12B3), 60 +/- 8 for rscu-PA (p < 0.001 versus both conjugates), and 380 +/- 66 for rt-PA (p < 0.001 versus both conjugates). The plasma clearances of the conjugates were fourfold to sixfold slower than those of rscu-PA and rt-PA. Maximal rates of clot lysis, determined by continuous external radioisotope scanning over the thorax, were 0.90 +/- 0.13%, 0.91 +/- 0.17%, 0.84 +/- 0.12%, and 1.1 +/- 0.16% lysis per minute for rscu-PA/MA-12B3, rscu-PA/MA-15C5, rscu-PA, and rt-PA, respectively; these maximal rates were obtained with 0.016, 0.016, 1.0, and 0.25 mg/kg, respectively, and were associated with minimal lag phases of 18 +/- 3.2, 28 +/- 4.9, 34 +/- 3.7, and 25 +/- 3.9 minutes, respectively. CONCLUSIONS The thrombolytic potency of the rscu-PA/antifibrin conjugates is determined by their clearance, as well as by rate and extent of initial binding to clots and by changes in binding during clot lysis. Clot targeting of rscu-PA with fibrin-specific antibodies increases its thrombolytic potency but does not alter the maximal rate or the minimal lag phase of clot lysis. These parameters appear to be independent of the nature of the plasminogen activator and of targeting." @default.
- W1990523218 created "2016-06-24" @default.
- W1990523218 creator A5007259656 @default.
- W1990523218 creator A5015282498 @default.
- W1990523218 creator A5023982501 @default.
- W1990523218 creator A5054746181 @default.
- W1990523218 creator A5069224997 @default.
- W1990523218 creator A5069833027 @default.
- W1990523218 creator A5071619792 @default.
- W1990523218 date "1993-03-01" @default.
- W1990523218 modified "2023-10-10" @default.
- W1990523218 title "Thrombolytic profiles of clot-targeted plasminogen activators. Parameters determining potency and initial and maximal rates." @default.
- W1990523218 cites W118753831 @default.
- W1990523218 cites W1569099138 @default.
- W1990523218 cites W1773975057 @default.
- W1990523218 cites W2000276981 @default.
- W1990523218 cites W2003364720 @default.
- W1990523218 cites W2031308862 @default.
- W1990523218 cites W2033465249 @default.
- W1990523218 cites W2033870119 @default.
- W1990523218 cites W2037015749 @default.
- W1990523218 cites W2051512141 @default.
- W1990523218 cites W2057209113 @default.
- W1990523218 cites W2062957366 @default.
- W1990523218 cites W2075924144 @default.
- W1990523218 cites W2076134563 @default.
- W1990523218 cites W2076407505 @default.
- W1990523218 cites W2079159860 @default.
- W1990523218 cites W2081576889 @default.
- W1990523218 cites W2082095559 @default.
- W1990523218 cites W2087480868 @default.
- W1990523218 cites W2102276284 @default.
- W1990523218 cites W2116528972 @default.
- W1990523218 cites W2158661682 @default.
- W1990523218 cites W233118278 @default.
- W1990523218 cites W2399930235 @default.
- W1990523218 cites W2402440509 @default.
- W1990523218 cites W2416578303 @default.
- W1990523218 cites W2418339090 @default.
- W1990523218 cites W2462075820 @default.
- W1990523218 cites W2472542224 @default.
- W1990523218 cites W304824559 @default.
- W1990523218 cites W2406473837 @default.
- W1990523218 doi "https://doi.org/10.1161/01.cir.87.3.1007" @default.
- W1990523218 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8443877" @default.
- W1990523218 hasPublicationYear "1993" @default.
- W1990523218 type Work @default.
- W1990523218 sameAs 1990523218 @default.
- W1990523218 citedByCount "29" @default.
- W1990523218 countsByYear W19905232182012 @default.
- W1990523218 countsByYear W19905232182013 @default.
- W1990523218 countsByYear W19905232182015 @default.
- W1990523218 countsByYear W19905232182016 @default.
- W1990523218 countsByYear W19905232182021 @default.
- W1990523218 countsByYear W19905232182023 @default.
- W1990523218 crossrefType "journal-article" @default.
- W1990523218 hasAuthorship W1990523218A5007259656 @default.
- W1990523218 hasAuthorship W1990523218A5015282498 @default.
- W1990523218 hasAuthorship W1990523218A5023982501 @default.
- W1990523218 hasAuthorship W1990523218A5054746181 @default.
- W1990523218 hasAuthorship W1990523218A5069224997 @default.
- W1990523218 hasAuthorship W1990523218A5069833027 @default.
- W1990523218 hasAuthorship W1990523218A5071619792 @default.
- W1990523218 hasBestOaLocation W19905232181 @default.
- W1990523218 hasConcept C126322002 @default.
- W1990523218 hasConcept C159654299 @default.
- W1990523218 hasConcept C185592680 @default.
- W1990523218 hasConcept C202751555 @default.
- W1990523218 hasConcept C203014093 @default.
- W1990523218 hasConcept C2776572282 @default.
- W1990523218 hasConcept C2776892390 @default.
- W1990523218 hasConcept C2779581417 @default.
- W1990523218 hasConcept C2779679481 @default.
- W1990523218 hasConcept C2781362458 @default.
- W1990523218 hasConcept C500558357 @default.
- W1990523218 hasConcept C54173615 @default.
- W1990523218 hasConcept C542903549 @default.
- W1990523218 hasConcept C55493867 @default.
- W1990523218 hasConcept C57409179 @default.
- W1990523218 hasConcept C57992300 @default.
- W1990523218 hasConcept C71924100 @default.
- W1990523218 hasConcept C98274493 @default.
- W1990523218 hasConceptScore W1990523218C126322002 @default.
- W1990523218 hasConceptScore W1990523218C159654299 @default.
- W1990523218 hasConceptScore W1990523218C185592680 @default.
- W1990523218 hasConceptScore W1990523218C202751555 @default.
- W1990523218 hasConceptScore W1990523218C203014093 @default.
- W1990523218 hasConceptScore W1990523218C2776572282 @default.
- W1990523218 hasConceptScore W1990523218C2776892390 @default.
- W1990523218 hasConceptScore W1990523218C2779581417 @default.
- W1990523218 hasConceptScore W1990523218C2779679481 @default.
- W1990523218 hasConceptScore W1990523218C2781362458 @default.
- W1990523218 hasConceptScore W1990523218C500558357 @default.
- W1990523218 hasConceptScore W1990523218C54173615 @default.
- W1990523218 hasConceptScore W1990523218C542903549 @default.
- W1990523218 hasConceptScore W1990523218C55493867 @default.
- W1990523218 hasConceptScore W1990523218C57409179 @default.
- W1990523218 hasConceptScore W1990523218C57992300 @default.